Shares of Elekta AB (publ) (OTCMKTS:EKTAY – Get Free Report) reached a new 52-week low on Tuesday . The stock traded as low as $5.25 and last traded at $5.25, with a volume of 2333 shares traded. The stock had previously closed at $5.46.
Elekta AB (publ) Price Performance
The company has a debt-to-equity ratio of 0.45, a current ratio of 0.99 and a quick ratio of 0.74. The firm has a market capitalization of $2.01 billion, a PE ratio of 21.00 and a beta of 1.23. The business’s 50 day moving average is $5.92 and its two-hundred day moving average is $6.24.
About Elekta AB (publ)
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.
Featured Articles
- Five stocks we like better than Elekta AB (publ)
- Retail Stocks Investing, Explained
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- Are Penny Stocks a Good Fit for Your Portfolio?
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- The Role Economic Reports Play in a Successful Investment Strategy
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for Elekta AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elekta AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.